Company Profile
Gan & Lee Pharmaceuticals., a biopharmaceutical company provides the development, production, and commercialization of insulin analogs and medical devices in China. Its products include Basalin, an insulin glargine injection.
Its portfolio also includes Prandilin, an insulin lispro injection, Prandilin 25, an insulin lispro mix 75/25 injection, Rapilin, an insulin aspart injection, Rapilin 30, an insulin aspart 30 injection, and Similin 30, a mixed protamine human insulin injection
GanleePen, an insulin injection device; and GanleeFine, an insulin pen needle. in April 2005. Gan & Lee Pharmaceuticals. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.